Medical experts previously believed that multiple sclerosis may develop from deep inside the brain going out. But researchers have recently discovered that this may not be the case. There are also indications that MS may develop from the outermost parts of the brain going deeper.
A collaborative effort between researchers from Mayo Clinic and the Cleveland Clinic have indicated that multiple sclerosis may develop f... Researchers Discover MS Starts In Brain’s Outer Layers
Posted by dennis on December 13th, 2011
Medical experts previously believed that multiple sclerosis may develop from deep inside the brain going out. But researchers have recently discovered that this may not be the case. There are also indications that MS may develop from the outermost parts of the brain going deeper.
A collaborative effort between researchers from Mayo Clinic and the Cleveland Clinic have indicated that multiple sclerosis may develop f... Oral MS Drug Mechanism Known
Posted by dennis on December 6th, 2011
An oral drug called laquinimod has been undergoing clinical trial and has so far been effective in treating relapsing-remitting MS. But the mechanism behind its effective treatment of MS has not been fully understood by researchers. A recent study on the oral MS drug will provide added insight on how the said drug works in treating the debilitating disease affecting millions of people worldwide.
According to resear... MS Drug Reduces Relapse Rate By Half In Late Stage Trial
Posted by dennis on November 22nd, 2011
A new multiple sclerosis drug has been showing quite a promise in reducing relapse rates in people who suffer from the said disease. The experimental MS drug called alemtuzumab (Lemtrada) from Genzyme has been showing that it can reduce relapse rates of MS by as much as 50 percent. It is also seen to be effective in lowering the risk of worsening disabilities by around 40 percent as exhibited at the late stage tria... Potential Biomarker Identified For Early Diagnosis Of MS
Posted by dennis on November 15th, 2011
Researchers have identified a potential biomarker that can be used to diagnose for certain degenerative brain conditions such as multiple sclerosis. Certain changes exhibited by tissues located at the junction of the outer and inner layers of the brain called “blurring” may indicate the level of cognitive decline and may be used for early diagnosis of diseases like MS as well as develop new therapies fo... Saffron Ingredient Show MS Treatment Potential
Posted by dennis on November 8th, 2011
Researchers from the University of Alberta have discovered a potential treatment for multiple sclerosis found in the ancient Persian spice saffron. It may also provide a potential treatment for a number of other diseases that may involve neuroinflammation. The findings were recently published in The Journal of Immunology.
Chris Power and his team of researchers from the Faculty of Medicine ad Dentistry of Universit... High Doses Of Vitamin D Not Any Better Than Low Dosages For MS
Posted by dennis on October 25th, 2011
A new study has found out that getting high dosage of vitamin D may not provide any beneficial effects for MS patients better than what a low dose of vitamin D already can provide. This issue has been up for debate for quite awhile now and how low vitamin D levels have been associated with increased MS risk. The study findings are published in the October 25 issue of Neurology, the medical journal of the American A... Researchers Find New Stem Cell Isolation Method For MS Treatment
Posted by dennis on October 18th, 2011
MS treatment using stem cells may become a very promising prospect in the very near future. This prospect may even be getting closer and closer as researchers are indicating that human clinical trials using stem cells to treat MS may not be that afar off. Researchers from the University of Buffalo and the University of Rochester have found a more precise way of isolating stem cells in the brain that can be used to ... New Oral Drug Found to Reduce Relapses in Multiple Sclerosis Patients
Posted by dennis on October 11th, 2011
There is some good news for a great number of MS sufferers. A large international clinical trial has provided some good results on an oral drug that was developed to treat people with multiple sclerosis. The results are showing that the said oral drug seems to significantly reduce the relapse rate of the said disease as well as slow down its progression. The results of the clinical trial were recently published in ... Researchers Discover New Type Of Spinal Cord Stem Cell
Posted by dennis on October 4th, 2011
A team of researchers may have found a potential treatment approach using stem cells for conditions that affect the spinal cord or the central nervous system. They have discovered a type of spinal cord cell that can function as a stem cell. This can be sued to help regenerate damaged portions of the spinal cord or the central nervous system as seen in conditions such as multiple sclerosis, amyotrophic lateral scler... New Imaging Technique Provide Better View Of Nerve Damage
Posted by dennis on September 28th, 2011
A new imaging technique was recently developed that would allow doctors and researchers to view the extent of nerve damage more clearly in a live patient. This will also help researchers to assess and evaluate the level of damage as well as healing of the nerve tissues more accurately. This new imaging method is further described in the September issue of Biomedical Optics Express, the open access journal of the Op...